Prescriptions; off-label use. (SB711)
Introduced By
Sen. Amanda Chase (R-Midlothian)
Progress
✓ |
Introduced |
✗ |
Passed Committee |
☐ |
Passed House |
☐ |
Passed Senate |
☐ |
Signed by Governor |
☐ |
Became Law |
Description
Prescriptions; off-label use. Provides that a licensed health care provider with prescriptive authority may prescribe, administer, or dispense a drug that has been approved for a specific use by the U.S. Food and Drug Administration for an off-label use when the health care provider determines, in his professional judgment, that such off-label use is appropriate for the care and treatment of the patient and prohibits a pharmacist from refusing to dispense a drug for off-label use if a valid prescription is presented. Read the Bill »
Outcome
Bill Has Failed
History
Date | Action |
---|---|
01/21/2022 | Presented and ordered printed 22104615D |
01/21/2022 | Referred to Committee on Education and Health |
01/25/2022 | Assigned Education sub: Health Professions |
01/28/2022 | Impact statement from DPB (SB711) |
02/10/2022 | Senate committee, floor amendments and substitutes offered |
02/10/2022 | Passed by indefinitely in Education and Health (9-Y 6-N) (see vote tally) |
Post a Public Comment About this Bill